Thrombosis et diathesis haemorrhagica, 0340-6245

Journal

More filtering options
  1. 2019
  2. The Ultimate Murine Model of Immune Thrombocytopaenia

    John W. Semple & Kapur, R., 2019, In : Thrombosis and Haemostasis. 119, 3, p. 353-354 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  3. 2018
  4. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients

    Lind-Halldén, C., Manderstedt, E., Carlberg, D., Lethagen, S. & Halldén, C., 2018 Jul 4, In : Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  5. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

    Stanne, T. M., Olsson, M., Lorentzen, E., Pedersen, A., Gummesson, A., Gils, A., Jood, K., Gunnar Engström, Olle Melander, Declerck, P. J. & Jern, C., 2018, In : Thrombosis and Haemostasis. 118, 2, p. 298-308

    Research output: Contribution to journalArticle

  6. 2017
  7. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Mancuso, M. E., Fischer, K., Santagostino, E., Oldenburg, J., Platokouki, H., Escuriola-Ettingshausen, C., Rivard, G. E., Cid, A. R., Carcao, M., Ljung, R., Petrini, P., Altisent, C., Kenet, G., Kurnik, K., Auerswald, G., Chambost, H., Mäkipernaa, A., Molinari, A. C., Williams, M., van den Berg, H. M. & 1 othersEuropean Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 Dec, In : Thrombosis and Haemostasis. 117, 12, p. 2274-2282

    Research output: Contribution to journalArticle

  8. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

    Sandén, P., Renlund, H., Peter J. Svensson & Själander, A., 2017 Jan 1, In : Thrombosis and Haemostasis. 117, 1, p. 27-32 6 p.

    Research output: Contribution to journalArticle

  9. Extracellular nucleic acids in immunity and cardiovascular responses: Between alert and disease

    Preissner, K. T. & Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 7, p. 1272-1282 11 p.

    Research output: Contribution to journalReview article

  10. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

    Lallukka, S., Luukkonen, P. K., Zhou, Y., Isokuortti, E., Leivonen, M., Juuti, A., Hakkarainen, A., Marju Orho-Melander, Lundbom, N., Olkkonen, V. M., Lassila, R. & Yki-Järvinen, H., 2017, In : Thrombosis and Haemostasis. 117, 2, p. 286-294 9 p.

    Research output: Contribution to journalArticle

  11. Paracelsus, poison, and colistin

    Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 9, p. 1661 1 p.

    Research output: Contribution to journalDebate/Note/Editorial

  12. The importance of genetic factors for the development of arthropathy: A longitudinal study of children and adolescents with haemophilia A

    Gomperts, E. D., Schwarz, J., Donfield, S. M., Lail, A. E., Jan Astermark, Keith Hoots, W., Winkler, C. A. & Erik Berntorp, 2017, In : Thrombosis and Haemostasis. 117, 2, p. 277-285 9 p.

    Research output: Contribution to journalArticle

  13. 2016
  14. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

    Xiao Wang, Kristina Sundquist, Johan L. Elf, Strandberg, K., Peter J. Svensson, Hedelius, A., Palmér, K., Ashfaque A. Memon, Jan Sundquist & Bengt Zöller, 2016 Aug 1, In : Thrombosis and Haemostasis. 116, 2, p. 328-336 9 p.

    Research output: Contribution to journalArticle

  15. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    van den Berg, H. M., Hashemi, S. M., Fischer, K., Petrini, P., Rolf Ljung, Rafowicz, A., Carcao, M., Auerswald, G., Kurnik, K., Kenet, G. & Santagostino, E., 2016 Apr 1, In : Thrombosis and Haemostasis. 115, 4, p. 729-737 9 p.

    Research output: Contribution to journalArticle

  16. BRCA2 gene mutations and coagulation-associated biomarkers

    Perez-Segura, P., Zamorano-León, J. J., Acosta, D., Santos-Sancho, J. M., Modrego, J., Caldés, T., De La Hoya, M., Díaz-Rubio, E., Díaz-Millán, I., De Las Heras, N., Zalba, L. A. R., Lahera, V., Olle Melander & Farré, A. L., 2016, In : Thrombosis and Haemostasis. 115, 2, p. 415-423 9 p.

    Research output: Contribution to journalArticle

  17. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Fischer, K., Carcao, M., Santagostino, E., Manco-Johnson, M. J. & Mathew, P., 2016, In : Thrombosis and Haemostasis. 115, 5, p. 913-920

    Research output: Contribution to journalReview article

  18. 2015
  19. Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.

    Naudin, C., Hurley, S., Erik Malmström, Plug, T., Oonagh Shannon, Meijers, J. C. M., Mörgelin, M., Lars Björck & Heiko Herwald, 2015, In : Thrombosis and Haemostasis. 114, 4, p. 717-726

    Research output: Contribution to journalArticle

  20. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Somajo, S., Ahnström, J., Fernandez-Recio, J., Gierula, M., Villoutreix, B. O. & Björn Dahlbäck, 2015, In : Thrombosis and Haemostasis. 113, 5, p. 976-987

    Research output: Contribution to journalArticle

  21. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    Kohler, S., Hallström, T., Singh, B., Kristian Riesbeck, Sparta, G., Zipfel, P. F. & Hammerschmidt, S., 2015, In : Thrombosis and Haemostasis. 113, 1, p. 125-142

    Research output: Contribution to journalArticle

  22. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

    Strom, A. C., Cross, A. J., Cole, J. E., Blair, P. A., Leib, C., Goddard, M. E., Rosser, E. C., Park, I., Nilsson, A. H., Jan Nilsson, Mauri, C. & Monaco, C., 2015, In : Thrombosis and Haemostasis. 114, 4, p. 835-847

    Research output: Contribution to journalArticle

  23. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Dickneite, G., Heiko Herwald, Korte, W., Allanore, Y., Denton, C. P. & Cerinic, M. M., 2015, In : Thrombosis and Haemostasis. 113, 4, p. 686-697

    Research output: Contribution to journalReview article

  24. Genetic aspects of thrombotic disease

    Garcia de Frutos, P. & Bengt Zöller, 2015, In : Thrombosis and Haemostasis. 114, 5, p. 883-884

    Research output: Contribution to journalDebate/Note/Editorial

  25. Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula

    Sjogren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Peter Svensson & Sjalander, A., 2015, In : Thrombosis and Haemostasis. 113, 6, p. 1370-1377

    Research output: Contribution to journalArticle

  26. 2014
  27. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, James, S., Duvvuru, S., Jakubowski, J. A., Wagner, H., Varenhorst, C., Tantry, U. S., Brown, P. B., Small, D., Moser, B. A., Sundseth, S., Walker, J. R., Winters, K. J. & Gurbel, P. A., 2014, In : Thrombosis and Haemostasis. 111, 5, p. 943-950

    Research output: Contribution to journalArticle

  28. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories

    Solomon, C., Baryshnikova, E., Tripodi, A., Schlimp, C. J., Schoechl, H., Cadamuro, J., Dag Winstedt, Asmis, L. & Ranucci, M., 2014, In : Thrombosis and Haemostasis. 112, 1, p. 109-117

    Research output: Contribution to journalArticle

  29. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

    Blanchet, X., Cesarek, K., Brandt, J., Heiko Herwald, Teupser, D., Kuechenhoff, H., Karshovska, E., Mause, S. F., Siess, W., Wasmuth, H., Soehnlein, O., Koenen, R. R., Weber, C. & von Hundelshausen, P., 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1277-1287

    Research output: Contribution to journalArticle

  30. Targeted mass spectrometry analysis of neutrophil-derived proteins released during sepsis progression.

    Erik Malmström, Davidova, A., Mörgelin, M., Adam Linder, Larsen, M., Qvortrup, K., Pontus Nordenfelt, Oonagh Shannon, Dzupova, O., Holub, M., Johan Malmström & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1230-1243

    Research output: Contribution to journalArticle

  31. The coagulation system and its function in early immune defense.

    van der Poll, T. & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 4, p. 640-648

    Research output: Contribution to journalArticle

  32. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

    Gurbel, P. A., Bergmeijer, T. O., Tantry, U. S., ten Berg, J. M., Angiolillo, D. J., James, S., Lindahl, T. L., Peter Svensson, Jakubowski, J. A., Brown, P. B., Duvvuru, S., Sundseth, S., Walker, J. R., Small, D., Moser, B. A., Winters, K. J. & David Erlinge, 2014, In : Thrombosis and Haemostasis. 112, 3, p. 589-597

    Research output: Contribution to journalArticle

  33. 2013
  34. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, In : Thrombosis and Haemostasis. 109, 4, p. 582-582

    Research output: Contribution to journalDebate/Note/Editorial

  35. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, Angiolillo, D. J., Ferreiro, J. L., Jakubowski, J. A., Winters, K. J., Effron, M. B., Duvvuru, S., Costigan, T. M., Sundseth, S., Walker, J. R., Saucedo, J. F., Kleiman, N. S. & Varenhorst, C., 2013, In : Thrombosis and Haemostasis. 110, 6, p. 1223-1231

    Research output: Contribution to journalArticle

  36. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Calzavarini, S., Villoutreix, B. O., Lunghi, B., Livaja Koshiar, R., Bernardi, F. & Björn Dahlbäck, 2013, In : Thrombosis and Haemostasis. 110, 1, p. 31-38

    Research output: Contribution to journalArticle

  37. Old genes and new genes: The evolution of the kallikrein locus.

    Åke Lundwall, 2013, In : Thrombosis and Haemostasis. 109, 6

    Research output: Contribution to journalReview article

  38. 2012
  39. Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems

    Sen, P., Clark, C. A., Gopalakrishnan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Thrombosis and Haemostasis. 107, 5, p. 951-961

    Research output: Contribution to journalArticle

  40. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Högberg, C., Olof Gidlöf, Deflorian, F., Jacobson, K. A., Abdelrahman, A., Müller, C. E., Björn Olde & David Erlinge, 2012, In : Thrombosis and Haemostasis. 108, 1, p. 119-132

    Research output: Contribution to journalArticle

  41. Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

    Turpie, A. G. G., Kreutz, R., Llau, J., Bo Norrving & Haas, S., 2012, In : Thrombosis and Haemostasis. 108, 5, p. 876-886

    Research output: Contribution to journalArticle

  42. Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency

    Lind-Hallden, C., Dahlen, A., Andreas Hillarp, Bengt Zöller, Björn Dahlbäck & Hallden, C., 2012, In : Thrombosis and Haemostasis. 108, 1, p. 94-100

    Research output: Contribution to journalArticle

  43. Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?

    Gurbel, P. A., Roe, M. T., Jakubowski, J. A., Shah, S., David Erlinge, Goodman, S. G., Huber, K., Chan, M. Y., Cornel, J. H., Tantry, U. S. & Ohman, E. M., 2012, In : Thrombosis and Haemostasis. 108, 1, p. 12-20

    Research output: Contribution to journalReview article

  44. 2011
  45. A large deletion identified in a Swedish family with type 1 VWD

    Johansson, A. M., Lanke, E., Torbjörn Säll, Lethagen, S. & Halldén, C., 2011, In : Thrombosis and Haemostasis. 105, 4, p. 733-734

    Research output: Contribution to journalLetter

  46. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, M. V., Plug, T., Marquart, J. A., Marx, P. F., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2011, In : Thrombosis and Haemostasis. 106, 4, p. 609-616

    Research output: Contribution to journalArticle

  47. Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives

    Erik Berntorp, Escuriola-Ettingshausen, C., Khair, K., Kreuz, W., Montano, C. & Zozulya, N., 2011, In : Thrombosis and Haemostasis. 105, 3, p. A4-A14

    Research output: Contribution to journalDebate/Note/Editorial

  48. Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?

    Giangrande, P., von Depka, M., Kessler, C. M., Kannicht, C. & Rolf Ljung, 2011, In : Thrombosis and Haemostasis. 106, 3, p. 5-14

    Research output: Contribution to journalArticle

  49. 2010
  50. Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

    Bertil Olsson, Rasmussen, L. H., Tveit, A., Jensen, E., Wessman, P., Panfilov, S. & Wåhlander, K., 2010, In : Thrombosis and Haemostasis. 103, Jan 13, p. 604-612

    Research output: Contribution to journalArticle

  51. The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype

    Yamazaki, T., Okada, H., Balling, K., Björn Dahlbäck & Nicolaes, G., 2010, In : Thrombosis and Haemostasis. 104, 4, p. 860-861

    Research output: Contribution to journalLetter

Previous 1 2 3 Next